医学
黄斑变性
人工智能
介绍
金标准(测试)
光学相干层析成像
验光服务
德尔菲法
医学物理学
模式
机器学习
梅德林
计算机科学
联营
算法
眼科
参考数据
图像处理
作者
Amitha Domalpally,Emily Y. Chew,Malvina Eydelman,Tiarnán D.L. Keenan,Pearse A. Keane,Aaron Lee,Cecilia S. Lee,Eleonora M. Lad,Jennifer I. Lim,Anat Löwenstein,Ursula Schmidt-Erfurth,Michael D. Abramoff
标识
DOI:10.1016/j.ophtha.2026.04.013
摘要
Abstract –
Purpose
Artificial intelligence (AI)-based screening models hold promise for identifying individuals with undiagnosed age-related macular degeneration (AMD) in non-specialist settings. A standardized reference framework for image labeling is needed to enable consistent training, validation, and deployment of AI based screening algorithms.The goal of the present study is to establish expert consensus on image -based reference standard for labeling AMD Design
Modified Delphi consensus study Subjects/ Participants: fellowship-trained retina specialists, ophthalmologists, AI specialists, and imaging specialists Methods
A prespecified Delphi process was conducted using structured surveys . Over two rounds, panelists assessed opinions on existing reference standards, including the AREDS scale and Beckman scale, as well as imaging modalities such as color, optical coherence tomography (OCT), and autofluorescence. The surveys also evaluated imaging features of AMD, including drusen, pseudodrusen, and pigment changes, as well as referral criteria. Consensus was defined using a 9-point Likert scale, with predefined statistical thresholds for agreement. Main Outcome Measures
Agreement on key elements of a reference standard Results
Consensus was reached on adopting the Beckman Classification as the level 1 reference standard (median score 8; agreement). OCT use for identifying key AMD features, including drusen, GA, and CNV, also reached consensus (median scores 8.5–9; agreement). Pigment change detection did not reach consensus (median 7.5; uncertain), and screening age thresholds showed non-consensus (median 8; uncertain). Referral thresholds reached consensus, including urgent referral for neovascular AMD and non-urgent referral for GA and intermediate AMD (median 9; agreement). Conclusions
This study defines a consensus-based reference standard for labeling AMD from images for AI based screening. These recommendations are intended to support consistent AI model development and evaluation, while remaining distinct from clinical practice guidelines.Introduction
科研通智能强力驱动
Strongly Powered by AbleSci AI